Advertisement

Rhadinoviruses: KSHV and Associated Malignancies

  • Susann Santag
  • Thomas F. Schulz
Chapter
Part of the Current Cancer Research book series (CUCR)

Abstract

Kaposi’s Sarcoma Herpesvirus (KSHV), discovered in 1994, is the only known Rhadinovirus (γ2-herpesvirus) to naturally infect humans. In addition to Kaposi’s Sarcoma (KS), one of the most common HIV-associated malignancies, KSHV is strongly associated with two rare lymphoproliferative disorders, namely, primary effusion lymphoma (PEL) and the plasmablastic variant of multicentric Castleman’s disease (MCD). Epidemiological arguments strongly link KSHV to KS and KSHV is found in endothelial spindle cells, the neoplastic component of KS. This tumour appears to be the result of an oligo/polyclonal expansion of atypically differentiated, but not fully transformed, endothelial cells accompanied by pronounced inflammatory and angiogenic features. The plasma cells variant of MCD is characterised by a proliferation of monotypic, KSHV-infected B-cell population with plasmablastic features. By contrast, PEL represents a monoclonal, fully transformed, malignant B-cell proliferation with the survival of PEL cells, depending on the presence of latent KSHV proteins. Co-factors such as immunosuppression, and perhaps also immune activation, play an important role in KSHV-induced oncogenesis.

Keywords

Primary Effusion Lymphoma Lytic Replication KSHV Infection Primary Effusion Lymphoma Cell Primary Effusion Lymphoma Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. CDC (1981) Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men-New York City and California. MMWR 30(25):305–308Google Scholar
  2. Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I (2008) Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infect Dis 8:111PubMedGoogle Scholar
  3. Alkharsah KR, Dedicoat M, Blasczyk R, Newton R, Schulz TF (2007) Influence of HLA alleles on shedding of Kaposi sarcoma-associated herpesvirus in saliva in an African population. J Infect Dis 195(6):809–816PubMedGoogle Scholar
  4. Andreoni M, Sarmati L, Nicastri E, El Sawaf G, El Zalabani M, Uccella I, Bugarini R, Parisi SG, Rezza G (2002) Primary human herpesvirus 8 infection in immunocompetent children. JAMA 287(10):1295–1300PubMedGoogle Scholar
  5. Antman K, Chang Y (2000) Kaposi’s sarcoma. N Engl J Med 342(14):1027–1038PubMedGoogle Scholar
  6. Aoki Y, Jaffe ES, Chang Y, Jones K, Teruya-Feldstein J, Moore PS, Tosato G (1999) Angiogenesis and hematopoiesis induced by Kaposi’s sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93(12):4034–4043PubMedGoogle Scholar
  7. Aoki Y, Narazaki M, Kishimoto T, Tosato G (2001) Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus. Blood 98(10):3042–3049PubMedGoogle Scholar
  8. Aoki Y, Tosato G (2007) Interactions between HIV-1 Tat and KSHV. Curr Top Microbiol Immunol 312:309–326PubMedGoogle Scholar
  9. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E (1997) Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385(6614):347–350PubMedGoogle Scholar
  10. Ascoli V, Scalzo CC, Danese C, Vacca K, Pistilli A, Lo Coco F (1999) Human herpes virus-8 associated primary effusion lymphoma of the pleural cavity in HIV-negative elderly men. Eur Respir J 14(5):1231–1234PubMedGoogle Scholar
  11. Ascoli V, Senis G, Zucchetto A, Valerio L, Facchinelli L, Budroni M, Dal Maso L, Coluzzi M (2009) Distribution of ‘promoter’ sandflies associated with incidence of classic Kaposi’s sarcoma. Med Vet Entomol 23(3):217–225PubMedGoogle Scholar
  12. Atkinson JO, Biggar RJ, Goedert JJ, Engels EA (2004) The incidence of Kaposi sarcoma among injection drug users with AIDS in the United States (1999). J Acquir Immune Defic Syndr 37(2):1282–1287PubMedGoogle Scholar
  13. Baillargeon J, Deng JH, Hettler E, Harrison C, Grady JJ, Korte LG, Alexander J, Montalvo E, Jenson HB, Gao SJ (2001) Seroprevalence of Kaposi’s sarcoma-associated herpesvirus infection among blood donors from Texas. Ann Epidemiol 11(7):512–518PubMedGoogle Scholar
  14. Bais C, Van Geelen A, Eroles P, Mutlu A, Chiozzini C, Dias S, Silverstein RL, Rafii S, Mesri EA (2003) Kaposi’s sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/KDR. Cancer Cell 3(2):131–143PubMedGoogle Scholar
  15. Beral V, Peterman TA, Berkelman RL, Jaffe HW (1990) Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335(8682):123–128PubMedGoogle Scholar
  16. Berezne A, Agbalika F, Oksenhendler E (2004) Failure of cidofovir in HIV-associated multicentric Castleman disease. Blood 103(11):4368–4369, author reply 4369PubMedGoogle Scholar
  17. Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F (2000) Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis 181(5):1562–1568PubMedGoogle Scholar
  18. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO, Weiss RA, O’Leary JJ (1995) Kaposi’s sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1(12):1274–1278PubMedGoogle Scholar
  19. Boulanger E, Gerard L, Gabarre J, Molina JM, Rapp C, Abino JF, Cadranel J, Chevret S, Oksenhendler E (2005) Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol 23(19):4372–4380PubMedGoogle Scholar
  20. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009) A review of human carcinogens-Part B: biological agents. Lancet Oncol 10(4):321–322PubMedGoogle Scholar
  21. Bower M, Weir J, Francis N, Newsom-Davis T, Powles S, Crook T, Boffito M, Gazzard B, Nelson M (2009) The effect of HAART in 254 consecutive patients with AIDS-related Kaposi’s sarcoma. AIDS 23(13):1701–1706PubMedGoogle Scholar
  22. Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, Brennan MF (1999) The management of unicentric and multicentric Castleman’s disease: a report of 16 cases and a review of the literature. Cancer 85(3):706–717PubMedGoogle Scholar
  23. Brander C, Raje N, O’Connor PG, Davies F, Davis J, Chauhan D, Hideshima T, Martin J, Osmond D, Kedes DH, Walker BD, Scadden DT, Anderson KC (2002) Absence of biologically important Kaposi sarcoma-associated herpesvirus gene products and virus-specific cellular immune responses in multiple myeloma. Blood 100(2):698–700PubMedGoogle Scholar
  24. Brimo F, Michel RP, Khetani K, Auger M (2007) Primary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis. Cancer 111(4):224–233PubMedGoogle Scholar
  25. Brinkmann MM, Pietrek M, Dittrich-Breiholz O, Kracht M, Schulz TF (2007) Modulation of host gene expression by the K15 protein of Kaposi’s sarcoma-associated herpesvirus. J Virol 81(1):42–58PubMedGoogle Scholar
  26. Brown EE, Fallin D, Ruczinski I, Hutchinson A, Staats B, Vitale F, Lauria C, Serraino D, Rezza G, Mbisa G, Whitby D, Messina A, Goedert JJ, Chanock SJ (2006a) Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity. Cancer Epidemiol Biomarkers Prev 15(5):926–934PubMedGoogle Scholar
  27. Brown EE, Whitby D, Vitale F, Marshall V, Mbisa G, Gamache C, Lauria C, Alberg AJ, Serraino D, Cordiali-Fei P, Messina A, Goedert JJ (2006b) Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma. Cancer 107(9):2282–2290PubMedGoogle Scholar
  28. Butler LM, Dorsey G, Hladik W, Rosenthal PJ, Brander C, Neilands TB, Mbisa G, Whitby D, Kiepiela P, Mosam A, Mzolo S, Dollard SC, Martin JN (2009) Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission. J Infect Dis 200(3):430–438PubMedGoogle Scholar
  29. Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR (2005) Kaposi’s sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 102(15):5570–5575PubMedGoogle Scholar
  30. Cancer ICoHa (2000) Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92(22):1823–1830Google Scholar
  31. Cannon MJ, Operskalski EA, Mosley JW, Radford K, Dollard SC (2009) Lack of evidence for human herpesvirus-8 transmission via blood transfusion in a historical US cohort. J Infect Dis 199(11):1592–1598PubMedGoogle Scholar
  32. Carbone A, Cilia AM, Gloghini A, Capello D, Perin T, Bontempo D, Canzonieri V, Tirelli U, Volpe R, Gaidano G (2000) Primary effusion lymphoma cell lines harbouring human herpesvirus type-8. Leuk Lymphoma 36(5–6):447–456PubMedGoogle Scholar
  33. Carbone A, Gloghini A, Larocca LM, Capello D, Pierconti F, Canzonieri V, Tirelli U, Dalla-Favera R, Gaidano G (2001) Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 97(3):744–751PubMedGoogle Scholar
  34. Carrieri MP, Pradier C, Piselli P, Piche M, Rosenthal E, Heudier P, Durant J, Serraino D (2003) Reduced incidence of Kaposi’s sarcoma and of systemic non-hodgkin’s lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer 103(1):142–144PubMedGoogle Scholar
  35. Casper C (2006) Defining a role for antiviral drugs in the treatment of persons with HHV-8 infection. Herpes 13(2):42–47PubMedGoogle Scholar
  36. Casper C, Carrell D, Miller KG, Judson FD, Meier AS, Pauk JS, Morrow RA, Corey L, Wald A, Celum C (2006) HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study. Sex Transm Infect 82(3):229–235PubMedGoogle Scholar
  37. Casper C, Nichols WG, Huang ML, Corey L, Wald A (2004) Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 103(5):1632–1634PubMedGoogle Scholar
  38. Cassar O, Afonso PV, Bassot S, Plancoulaine S, Duprez R, Capuano C, Abel M, Martin PM, Gessain A (2007) Novel human herpesvirus 8 subtype D strains in Vanuatu, Melanesia. Emerg Infect Dis 13(11):1745–1748PubMedGoogle Scholar
  39. Cassar O, Bassot S, Plancoulaine S, Quintana-Murci L, Harmant C, Gurtsevitch V, Senyuta NB, Yakovleva LS, de The G, Gessain A (2010) Human herpesvirus 8, Southern Siberia. Emerg Infect Dis 16(3):580–582PubMedGoogle Scholar
  40. Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9(4):822–830PubMedGoogle Scholar
  41. Cattani P, Capuano M, Cerimele F, La Parola IL, Santangelo R, Masini C, Cerimele D, Fadda G (1999) Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi’s sarcoma. J Clin Microbiol 37(4):1150–1153PubMedGoogle Scholar
  42. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332(18):1186–1191PubMedGoogle Scholar
  43. Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, Chang Y, Knowles DM (1996) Kaposi’s sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi’s sarcoma and malignant lymphoma. J Virol 70(11):8218–8223PubMedGoogle Scholar
  44. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266(5192):1865–1869PubMedGoogle Scholar
  45. Chang Y, Moore PS, Talbot SJ, Boshoff CH, Zarkowska T, Godden K, Paterson H, Weiss RA, Mittnacht S (1996) Cyclin encoded by KS herpesvirus. Nature 382(6590):410PubMedGoogle Scholar
  46. Chatlynne LG, Ablashi DV (1999) Seroepidemiology of Kaposi’s sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol 9(3):175–185PubMedGoogle Scholar
  47. Chen YB, Rahemtullah A, Hochberg E (2007) Primary effusion lymphoma. Oncologist 12(5):569–576PubMedGoogle Scholar
  48. Cho MS, Choi HJ, Park HK, Cho SE, Han WS, Yang WI (2007) Questionable role of human herpesviruses in the pathogenesis of Kikuchi disease. Arch Pathol Lab Med 131(4):604–609PubMedGoogle Scholar
  49. Choi J, Means RE, Damania B, Jung JU (2001) Molecular piracy of Kaposi’s sarcoma associated herpesvirus. Cytokine Growth Factor Rev 12(2–3):245–257PubMedGoogle Scholar
  50. Cool CD, Rai PR, Yeager ME, Hernandez-Saavedra D, Serls AE, Bull TM, Geraci MW, Brown KK, Routes JM, Tuder RM, Voelkel NF (2003) Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med 349(12):1113–1122PubMedGoogle Scholar
  51. Corbellino M, Bestetti G, Scalamogna C, Calattini S, Galazzi M, Meroni L, Manganaro D, Fasan M, Moroni M, Galli M, Parravicini C (2001) Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 98(12):3473–3475PubMedGoogle Scholar
  52. Cunha AM, Caterino-de-Araujo A, Costa SC, Santos-Fortuna E, Boa-Sorte NC, Goncalves MS, Costa FF, Galvao-Castro B (2005) Increasing seroprevalence of human herpesvirus 8 (HHV-8) with age confirms HHV-8 endemicity in Amazon Amerindians from Brazil. J Gen Virol 86(Pt 9):2433–2437PubMedGoogle Scholar
  53. Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, Russo A, Intrieri T, Vercelli M, Zambon P, Tagliabue G, Zanetti R, Federico M, Limina RM, Mangone L, De Lisi V, Stracci F, Ferretti S, Piffer S, Budroni M, Donato A, Giacomin A, Bellu F, Fusco M, Madeddu A, Vitarelli S, Tessandori R, Tumino R, Suligoi B, Franceschi S (2009) Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 100(5):840–847PubMedGoogle Scholar
  54. Dargent JL, Lespagnard L, Sirtaine N, Cantinieaux B, Li R, Hermans P (2007) Plasmablastic microlymphoma occurring in human herpesvirus 8 (HHV-8)-positive multicentric Castleman’s disease and featuring a follicular growth pattern. APMIS 115(7):869–874PubMedGoogle Scholar
  55. Davis MA, Sturzl MA, Blasig C, Schreier A, Guo HG, Reitz M, Opalenik SR, Browning PJ (1997) Expression of human herpesvirus 8-encoded cyclin D in Kaposi’s sarcoma spindle cells. J Natl Cancer Inst 89(24):1868–1874PubMedGoogle Scholar
  56. De Clercq E (2003) Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev 16(4):569–596PubMedGoogle Scholar
  57. de Sanjose S, Goedert JJ, Marshall V, Bellas C, Benavente Y, Bosch R, Domingo A, Fernandez de Sevilla A, Servitje O, Whitby D (2004) Risk of malignant lymphoma associated with human herpesvirus-8: a case-control study in Spain. Br J Cancer 90(11):2145–2148PubMedGoogle Scholar
  58. de Sanjose S, Mbisa G, Perez-Alvarez S, Benavente Y, Sukvirach S, Hieu NT, Shin HR, Anh PT, Thomas J, Lazcano E, Matos E, Herrero R, Munoz N, Molano M, Franceschi S, Whitby D (2009) Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission. J Infect Dis 199(10):1449–1456PubMedGoogle Scholar
  59. Dedicoat M, Newton R (2003) Review of the distribution of Kaposi’s sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi’s sarcoma. Br J Cancer 88(1):1–3PubMedGoogle Scholar
  60. Dedicoat M, Newton R, Alkharsah KR, Sheldon J, Szabados I, Ndlovu B, Page T, Casabonne D, Gilks CF, Cassol SA, Whitby D, Schulz TF (2004) Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis 190(6):1068–1075PubMedGoogle Scholar
  61. Dezube BJ, Krown SE, Lee JY, Bauer KS, Aboulafia DM (2006) Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi’s sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol 24(9):1389–1394PubMedGoogle Scholar
  62. Di Alberti L, Piattelli A, Artese L, Favia G, Patel S, Saunders N, Porter SR, Scully CM, Ngui SL, Teo CG (1997) Human herpesvirus 8 variants in sarcoid tissues. Lancet 350(9092):1655–1661PubMedGoogle Scholar
  63. Dictor M, Rambech E, Way D, Witte M, Bendsoe N (1996) Human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus) DNA in Kaposi’s sarcoma lesions, AIDS Kaposi’s sarcoma cell lines, endothelial Kaposi’s sarcoma simulators, and the skin of immunosuppressed patients. Am J Pathol 148(6):2009–2016PubMedGoogle Scholar
  64. DiGiovanna JJ, Safai B (1981) Kaposi’s sarcoma. Retrospective study of 90 cases with particular emphasis on the familial occurrence, ethnic background and prevalence of other diseases. Am J Med 71(5):779–783PubMedGoogle Scholar
  65. Dilnur P, Katano H, Wang ZH, Osakabe Y, Kudo M, Sata T, Ebihara Y (2001) Classic type of Kaposi’s sarcoma and human herpesvirus 8 infection in Xinjiang, China. Pathol Int 51(11):845–852PubMedGoogle Scholar
  66. Dotti G, Fiocchi R, Motta T, Facchinetti B, Chiodini B, Borleri GM, Gavazzeni G, Barbui T, Rambaldi A (1999) Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia 13(5):664–670PubMedGoogle Scholar
  67. Douglas JL, Gustin JK, Dezube B, Pantanowitz JL, Moses AV (2007) Kaposi’s sarcoma: a model of both malignancy and chronic inflammation. Panminerva Med 49(3):119–138PubMedGoogle Scholar
  68. Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, Meignin V, Oksenhendler E, Boshoff C, Isaacson PG (2001) Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 97(7):2130–2136PubMedGoogle Scholar
  69. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95(4):1406–1412PubMedGoogle Scholar
  70. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K, Boshoff C (1999) Distribution of human herpesvirus-8 latently infected cells in Kaposi’s sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 96(8):4546–4551PubMedGoogle Scholar
  71. Dupin N, Grandadam M, Calvez V, Gorin I, Aubin JT, Havard S, Lamy F, Leibowitch M, Huraux JM, Escande JP et al (1995) Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi’s sarcoma. Lancet 345(8952):761–762PubMedGoogle Scholar
  72. Dupont C, Vasseur E, Beauchet A, Aegerter P, Berthe H, de Truchis P, Zucman D, Rouveix E, Saiag P (2000) Long-term efficacy on Kaposi’s sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d’information et de soins de l’immunodeficience humaine. AIDS 14(8):987–993PubMedGoogle Scholar
  73. Duprez R, Lacoste V, Briere J, Couppie P, Frances C, Sainte-Marie D, Kassa-Kelembho E, Lando MJ, Essame Oyono JL, Nkegoum B, Hbid O, Mahe A, Lebbe C, Tortevoye P, Huerre M, Gessain A (2007) Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma. J Natl Cancer Inst 99(14):1086–1094PubMedGoogle Scholar
  74. Engels EA, Atkinson JO, Graubard BI, McQuillan GM, Gamache C, Mbisa G, Cohn S, Whitby D, Goedert JJ (2007) Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 196(2):199–207PubMedGoogle Scholar
  75. Ensoli B, Nakamura S, Salahuddin SZ, Biberfeld P, Larsson L, Beaver B, Wong-Staal F, Gallo RC (1989) AIDS-Kaposi’s sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243(4888):223–226PubMedGoogle Scholar
  76. Fan W, Bubman D, Chadburn A, Harrington WJ Jr, Cesarman E, Knowles DM (2005) Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. J Virol 79(2):1244–1251PubMedGoogle Scholar
  77. Farge D (1993) Kaposi’s sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Eur J Med 2(6):339–343PubMedGoogle Scholar
  78. Frances C, Mouquet C, Calvez V (1999) Human herpesvirus 8 and renal transplantation. N Engl J Med 340(13):1045, author reply 1046PubMedGoogle Scholar
  79. Friborg J Jr, Kong W, Hottiger MO, Nabel GJ (1999) p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402(6764):889–894PubMedGoogle Scholar
  80. Friedman-Kien AE (1981) Disseminated Kaposi’s sarcoma syndrome in young homosexual men. J Am Acad Dermatol 5(4):468–471PubMedGoogle Scholar
  81. Fujimuro M, Hayward SD (2003) The latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta. J Virol 77(14):8019–8030PubMedGoogle Scholar
  82. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS (1996) KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nat Med 2(8):925–928PubMedGoogle Scholar
  83. Gaspari AA, Marchese S, Powell D, Rady PL, Tyring SK (1997) Identification of HHV-8 DNA in the skin lesions of Kaposi’s sarcoma in an immunosuppressed patient with bullous pemphigoid. J Am Acad Dermatol 37(5 Pt 2):843–847PubMedGoogle Scholar
  84. Geddes M, Franceschi S, Barchielli A, Falcini F, Carli S, Cocconi G, Conti E, Crosignani P, Gafa L, Giarelli L et al (1994) Kaposi’s sarcoma in Italy before and after the AIDS epidemic. Br J Cancer 69(2):333–336PubMedGoogle Scholar
  85. George TI, Jones CD, Zehnder JL, Warnke RA, Dorfman RF (2003) Lack of human herpesvirus 8 and Epstein-Barr virus in Kikuchi’s histiocytic necrotizing lymphadenitis. Hum Pathol 34(2):130–135PubMedGoogle Scholar
  86. Glesby MJ, Hoover DR, Weng S, Graham NM, Phair JP, Detels R, Ho M, Saah AJ (1996) Use of antiherpes drugs and the risk of Kaposi’s sarcoma: data from the Multicenter AIDS Cohort Study. J Infect Dis 173(6):1477–1480PubMedGoogle Scholar
  87. Godden-Kent D, Talbot SJ, Boshoff C, Chang Y, Moore P, Weiss RA, Mittnacht S (1997) The cyclin encoded by Kaposi’s sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol 71(6):4193–4198PubMedGoogle Scholar
  88. Godfrey A, Anderson J, Papanastasiou A, Takeuchi Y, Boshoff C (2005) Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood 105(6):2510–2518PubMedGoogle Scholar
  89. Goedert JJ, Calamusa G, Dazzi C, Perna A, Pelser C, Anderson LA, Madsen C, Preiss LR, Airola M, Graubard BI, Messina A, Lauria C, Romano N (2010) Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily. Infect Agent Cancer 5(1):23PubMedGoogle Scholar
  90. Gompels UA, Kasolo FC (1996) HHV-8 serology and Kaposi’s sarcoma. Lancet 348(9041):1587–1588PubMedGoogle Scholar
  91. Gottlieb GJ, Ragaz A, Vogel JV, Friedman-Kien A, Rywlin AM, Weiner EA, Ackerman AB (1981) A preliminary communication on extensively disseminated Kaposi’s sarcoma in young homosexual men. Am J Dermatopathol 3(2):111–114PubMedGoogle Scholar
  92. Gottwein E, Cullen BR (2010) A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J Virol 84(10):5229–5237PubMedGoogle Scholar
  93. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR (2007) A viral microRNA functions as an orthologue of cellular miR-155. Nature 450(7172):1096–1099PubMedGoogle Scholar
  94. Goudsmit J, Renwick N, Dukers NH, Coutinho RA, Heisterkamp S, Bakker M, Schulz TF, Cornelissen M, Weverling GJ (2000) Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984–1997): analysis of seroconversions to ORF65 and ORF73. Proc Natl Acad Sci USA 97(9):4838–4843PubMedGoogle Scholar
  95. Grossmann C, Podgrabinska S, Skobe M, Ganem D (2006) Activation of NF-kappaB by the latent vFLIP gene of Kaposi’s sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J Virol 80(14):7179–7185PubMedGoogle Scholar
  96. Grulich AE, Olsen SJ, Luo K, Hendry O, Cunningham P, Cooper DA, Gao SJ, Chang Y, Moore PS, Kaldor JM (1999) Kaposi’s sarcoma-associated herpesvirus: a sexually transmissible infection? J Acquir Immune Defic Syndr Hum Retrovirol 20(4):387–393PubMedGoogle Scholar
  97. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370(9581):59–67PubMedGoogle Scholar
  98. Grundhoff A, Sullivan CS, Ganem D (2006) A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12(5):733–750PubMedGoogle Scholar
  99. Guasparri I, Keller SA, Cesarman E (2004) KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med 199(7):993–1003PubMedGoogle Scholar
  100. Guo HG, Pati S, Sadowska M, Charurat M, Reitz M (2004) Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. J Virol 78(17):9336–9342PubMedGoogle Scholar
  101. Guo HG, Sadowska M, Reid W, Tschachler E, Hayward G, Reitz M (2003) Kaposi’s sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J Virol 77(4):2631–2639PubMedGoogle Scholar
  102. Hansen PB, Penkowa M, Kirk O, Skinhoj P, Pedersen C, Lisse I, Kiss K, Zhou X, Hamilton-Dutoit SJ (2000) Human immunodeficiency virus-associated malignant lymphoma in eastern Denmark diagnosed from 1990–1996: clinical features, histopathology, and association with Epstein-Barr virus and human herpesvirus-8. Eur J Haematol 64(6):368–375PubMedGoogle Scholar
  103. Hayward GS (1999) KSHV strains: the origins and global spread of the virus. Semin Cancer Biol 9(3):187–199PubMedGoogle Scholar
  104. Henke-Gendo C, Mengel M, Hoeper MM, Alkharsah K, Schulz TF (2005) Absence of Kaposi’s sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 172(12):1581–1585PubMedGoogle Scholar
  105. Hladik W, Dollard SC, Mermin J, Fowlkes AL, Downing R, Amin MM, Banage F, Nzaro E, Kataaha P, Dondero TJ, Pellett PE, Lackritz EM (2006) Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 355(13):1331–1338PubMedGoogle Scholar
  106. Hocqueloux L, Agbalika F, Oksenhendler E, Molina JM (2001) Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy. AIDS 15(2):280–282PubMedGoogle Scholar
  107. Hoffman LJ, Bunker CH, Pellett PE, Trump DL, Patrick AL, Dollard SC, Keenan HA, Jenkins FJ (2004) Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer. J Infect Dis 189(1):15–20PubMedGoogle Scholar
  108. Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E (1997) Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi’s sarcoma-associated herpesvirus/human herpesvirus-8. Blood 90(3):1186–1191PubMedGoogle Scholar
  109. Huh J, Kang GH, Gong G, Kim SS, Ro JY, Kim CW (1998) Kaposi’s sarcoma-associated herpesvirus in Kikuchi’s disease. Hum Pathol 29(10):1091–1096PubMedGoogle Scholar
  110. Hutt MS, Burkitt D (1965) Geographical distribution of cancer in East Africa: a new clinicopathological approach. Br Med J 2(5464):719–722PubMedGoogle Scholar
  111. Jenkins FJ, Hayes RB, Jackson A, Pizza G, Mbisa G, Whitby D, Goedert JJ (2007) Human herpesvirus 8 seroprevalence among prostate cancer case patients and control subjects. J Infect Dis 196(2):208–211PubMedGoogle Scholar
  112. Jenner RG, Maillard K, Cattini N, Weiss RA, Boshoff C, Wooster R, Kellam P (2003) Kaposi’s sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Sci USA 100(18):10399–10404PubMedGoogle Scholar
  113. Judde JG, Lacoste V, Briere J, Kassa-Kelembho E, Clyti E, Couppie P, Buchrieser C, Tulliez M, Morvan J, Gessain A (2000) Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi’s sarcoma and other diseases. J Natl Cancer Inst 92(9):729–736PubMedGoogle Scholar
  114. Kaposi M (1872) Idiopathisches multiples Pigmentsarkomen der Haut. Arch Dermatol Syph 4:265–273Google Scholar
  115. Katano H, Ito K, Shibuya K, Saji T, Sato Y, Sata T (2005) Lack of human herpesvirus 8 infection in lungs of Japanese patients with primary pulmonary hypertension. J Infect Dis 191(5):743–745PubMedGoogle Scholar
  116. Katsume A, Saito H, Yamada Y, Yorozu K, Ueda O, Akamatsu K, Nishimoto N, Kishimoto T, Yoshizaki K, Ohsugi Y (2002) Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman’s disease like symptoms emerged in IL-6 transgenic mice. Cytokine 20(6):304–311PubMedGoogle Scholar
  117. Kazakov DV, Prinz BM, Michaelis S, Schmid M, Muller B, Adams V, Burg G, Kempf W (2002) Study of HHV-8 DNA sequences in archival biopsies from lesional skin of Kaposi’s sarcoma, various mesenchymal tumors and related reactive conditions. J Cutan Pathol 29(5):279–281PubMedGoogle Scholar
  118. Klaskala W, Brayfield BP, Kankasa C, Bhat G, West JT, Mitchell CD, Wood C (2005) Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia. J Med Virol 75(1):93–100PubMedGoogle Scholar
  119. Klass CM, Krug LT, Pozharskaya VP, Offermann MK (2005) The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production. Blood 105(10):4028–4034PubMedGoogle Scholar
  120. Klein U, Gloghini A, Gaidano G, Chadburn A, Cesarman E, Dalla-Favera R, Carbone A (2003) Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 101(10):4115–4121PubMedGoogle Scholar
  121. Kliche S, Kremmer E, Hammerschmidt W, Koszinowski U, Haas J (1998) Persistent infection of Epstein-Barr virus-positive B lymphocytes by human herpesvirus 8. J Virol 72(10):8143–8149PubMedGoogle Scholar
  122. Koon HB, Bubley GJ, Pantanowitz L, Masiello D, Smith B, Crosby K, Proper J, Weeden W, Miller TE, Chatis P, Egorin MJ, Tahan SR, Dezube BJ (2005) Imatinib-induced regression of AIDS-related Kaposi’s sarcoma. J Clin Oncol 23(5):982–989PubMedGoogle Scholar
  123. Koopal S, Furuhjelm JH, Jarviluoma A, Jaamaa S, Pyakurel P, Pussinen C, Wirzenius M, Biberfeld P, Alitalo K, Laiho M, Ojala PM (2007) Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis. PLoS Pathog 3(9):1348–1360PubMedGoogle Scholar
  124. Kouri V, Eng SM, Rodriguez ME, Resik S, Orraca O, Moore PS, Chang Y (2004) Seroprevalence of Kaposi’s sarcoma-associated herpesvirus in various populations in Cuba. Rev Panam de Salud Publica 15(5):320–325Google Scholar
  125. Lachant NA, Sun NC, Leong LA, Oseas RS, Prince HE (1985) Multicentric angiofollicular lymph node hyperplasia (Castleman’s disease) followed by Kaposi’s sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol 83(1):27–33PubMedGoogle Scholar
  126. Lagunoff M, Lukac DM, Ganem D (2001) Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi’s sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication. J Virol 75(13):5891–5898PubMedGoogle Scholar
  127. Lagunoff M, Majeti R, Weiss A, Ganem D (1999) Deregulated signal transduction by the K1 gene product of Kaposi’s sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 96(10):5704–5709PubMedGoogle Scholar
  128. Laney AS, Cannon MJ, Jaffe HW, Offermann MK, Ou CY, Radford KW, Patel MM, Spira TJ, Gunthel CJ, Pellett PE, Dollard SC (2007) Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi’s sarcoma. AIDS 21(12):1541–1545PubMedGoogle Scholar
  129. Lazzi S, Bellan C, Amato T, Palummo N, Cardone C, D’Amuri A, De Luca F, Beyanga M, Facchetti F, Tosi P, Leoncini L (2006) Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas? Hum Pathol 37(1):23–31PubMedGoogle Scholar
  130. Lazzi S, Ferrari F, Nyongo A, Palummo N, de Milito A, Zazzi M, Leoncini L, Luzi P, Tosi P (1998) HIV-associated malignant lymphomas in Kenya (Equatorial Africa). Hum Pathol 29(11):1285–1289PubMedGoogle Scholar
  131. Lebbe C, Agbalika F, Flageul B, Pellet C, Rybojad M, Cordoliani F, Farge D, Vignon-Pennamen MD, Sheldon J, Morel P, Calvo F, Schulz TF (1999) No evidence for a role of human herpesvirus type 8 in sarcoidosis: molecular and serological analysis. Br J Dermatol 141(3):492–496PubMedGoogle Scholar
  132. Lee BS, Alvarez X, Ishido S, Lackner AA, Jung JU (2000) Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi’s sarcoma-associated herpesvirus K1. J Exp Med 192(1):11–21PubMedGoogle Scholar
  133. Lee BS, Paulose-Murphy M, Chung YH, Connlole M, Zeichner S, Jung JU (2002) Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi’s sarcoma-associated herpesvirus by K1 signal transduction. J Virol 76(23):12185–12199PubMedGoogle Scholar
  134. Lee H, Veazey R, Williams K, Li M, Guo J, Neipel F, Fleckenstein B, Lackner A, Desrosiers RC, Jung JU (1998) Deregulation of cell growth by the K1 gene of Kaposi’s sarcoma-associated herpesvirus. Nat Med 4(4):435–440PubMedGoogle Scholar
  135. Lee JS, Li Q, Lee JY, Lee SH, Jeong JH, Lee HR, Chang H, Zhou FC, Gao SJ, Liang C, Jung JU (2009) FLIP-mediated autophagy regulation in cell death control. Nat Cell Biol 11(11):1355–1362PubMedGoogle Scholar
  136. Lei X, Bai Z, Ye F, Xie J, Kim CG, Huang Y, Gao SJ (2010) Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12(2):193–199PubMedGoogle Scholar
  137. Liang D, Gao Y, Lin X, He Z, Zhao Q, Deng Q, Lan K (2011) A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKvarepsilon. Cell Res. doi: 10.1038/cr.2011.5
  138. Lim SH, Beers SA, French RR, Johnson PW, Glennie MJ, Cragg MS (2010) Anti-CD20 monoclonal antibodies: historical and future perspectives. Haematologica 95(1):135–143PubMedGoogle Scholar
  139. Little RF, Gutierrez M, Jaffe ES, Pau A, Horne M, Wilson W (2001) HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis. Jama 285(14):1880–1885PubMedGoogle Scholar
  140. Liu C, Okruzhnov Y, Li H, Nicholas J (2001) Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects. J Virol 75(22):10933–10940PubMedGoogle Scholar
  141. Liu L, Eby MT, Rathore N, Sinha SK, Kumar A, Chaudhary PM (2002) The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J Biol Chem 277(16):13745–13751PubMedGoogle Scholar
  142. Luppi M, Barozzi P, Rasini V, Riva G, Re A, Rossi G, Setti G, Sandrini S, Facchetti F, Torelli G (2002) Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet. Transplantation 74(1):131–132PubMedGoogle Scholar
  143. Luppi M, Barozzi P, Schulz TF, Setti G, Staskus K, Trovato R, Narni F, Donelli A, Maiorana A, Marasca R, Sandrini S, Torelli G (2000) Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med 343(19):1378–1385PubMedGoogle Scholar
  144. MacKenzie J, Sheldon J, Morgan G, Cook G, Schulz TF, Jarrett RF (1997) HHV-8 and multiple myeloma in the UK. Lancet 350(9085):1144–1145PubMedGoogle Scholar
  145. Malope-Kgokong BI, Macphail P, Mbisa G, Ratshikhopha E, Maskew M, Stein L, Sitas F, Whitby D (2010) Kaposi’s Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa. Infect Agent Cancer 5:14PubMedGoogle Scholar
  146. Mann DJ, Child ES, Swanton C, Laman H, Jones N (1999) Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi’s sarcoma-associated herpesvirus. EMBO J 18(3):654–663PubMedGoogle Scholar
  147. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH (1998) Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 338(14):948–954PubMedGoogle Scholar
  148. Matolcsy A, Nador RG, Cesarman E, Knowles DM (1998) Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. Am J Pathol 153(5):1609–1614PubMedGoogle Scholar
  149. Mayama S, Cuevas LE, Sheldon J, Omar OH, Smith DH, Okong P, Silvel B, Hart CA, Schulz TF (1998) Prevalence and transmission of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 77(6):817–820PubMedGoogle Scholar
  150. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA (2003) Immune deficiency and risk for malignancy among persons with AIDS (1999). J Acquir Immune Defic Syndr 32(5):527–533PubMedGoogle Scholar
  151. McCarthy W, Pack GT (1950) Malignant blood vessel tumors; a report of 56 cases of angiosarcoma and Kaposi’s sarcoma. Surg Gynecol Obstet 91(4):465–482PubMedGoogle Scholar
  152. Melbye M, Cook PM, Hjalgrim H, Begtrup K, Simpson GR, Biggar RJ, Ebbesen P, Schulz TF (1998) Risk factors for Kaposi’s-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981–1996. Int J Cancer 77(4):543–548PubMedGoogle Scholar
  153. Memar OM, Rady PL, Goldblum RM, Yen A, Tyring SK (1997) Human herpesvirus 8 DNA sequences in blistering skin from patients with pemphigus. Arch Dermatol 133(10):1247–1251PubMedGoogle Scholar
  154. Mesri EA, Cesarman E, Boshoff C (2010) Kaposi’s sarcoma and its associated herpesvirus. Nat Rev 10(10):707–719Google Scholar
  155. Mikala G, Xie J, Berencsi G, Kiss C, Marton I, Domjan G, Valyi-Nagy I (1999) Human herpesvirus 8 in hematologic diseases. Pathol Oncol Res 5(1):73–79PubMedGoogle Scholar
  156. Minhas V, Brayfield BP, Crabtree KL, Kankasa C, Mitchell CD, Wood C (2010) Primary gamma-herpesviral infection in Zambian children. BMC Infect Dis 10:115PubMedGoogle Scholar
  157. Mohanna S, Maco V, Bravo F, Gotuzzo E (2005) Epidemiology and clinical characteristics of classic Kaposi’s sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease. Int J Infect Dis 9(5):239–250PubMedGoogle Scholar
  158. Mohanna S, Portillo JA, Carriquiry G, Vidal J, Ferrufino JC, Sanchez J, Bravo F, Gotuzzo E (2007) Human herpesvirus-8 in Peruvian blood donors: a population with hyperendemic disease? Clin Infect Dis 44(4):558–561PubMedGoogle Scholar
  159. Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y, Li Y, Ray PE, Gutkind JS (2003) Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi’s sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3(1):23–36PubMedGoogle Scholar
  160. Montaner S, Sodhi A, Pece S, Mesri EA, Gutkind JS (2001) The Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res 61(6):2641–2648PubMedGoogle Scholar
  161. Moore PS, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR, Parry JP, Conley LJ, Jaffe HW, Chang Y (1996) Kaposi’s sarcoma-associated herpesvirus infection prior to onset of Kaposi’s sarcoma. AIDS 10(2):175–180PubMedGoogle Scholar
  162. Moray G, Basaran O, Yagmurdur MC, Emiroglu R, Bilgin N, Haberal M (2004) Immunosuppressive therapy and Kaposi’s sarcoma after kidney transplantation. Transplant Proc 36(1):168–170PubMedGoogle Scholar
  163. Mori Y, Nishimoto N, Ohno M, Inagi R, Dhepakson P, Amou K, Yoshizaki K, Yamanishi K (2000) Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion. J Med Virol 61(3):332–335PubMedGoogle Scholar
  164. Mylona EE, Baraboutis IG, Lekakis LJ, Georgiou O, Papastamopoulos V, Skoutelis A (2008) Multicentric Castleman’s disease in HIV infection: a systematic review of the literature. AIDS Rev 10(1):25–35PubMedGoogle Scholar
  165. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, Knowles DM (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood 88(2):645–656PubMedGoogle Scholar
  166. Neipel F, Albrecht JC, Ensser A, Huang YQ, Li JJ, Friedman-Kien AE, Fleckenstein B (1997) Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 71(1):839–842PubMedGoogle Scholar
  167. Newton R, Carpenter L, Casabonne D, Beral V, Babiker A, Darbyshire J, Weller I, Weiss R, Kwan A, Bourboulia D, Munoz F, Lagos D, Boshoff C (2006) A prospective study of Kaposi’s sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1. Br J Cancer 94(10):1504–1509PubMedGoogle Scholar
  168. Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C (2003) Infection with Kaposi’s sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi’s sarcoma in Uganda. Br J Cancer 89(3):502–504PubMedGoogle Scholar
  169. Nickoloff BJ (1991) The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi’s sarcoma. Arch Dermatol 127(4):523–529PubMedGoogle Scholar
  170. Nickoloff BJ (1993) PECAM-1 (CD31) is expressed on proliferating endothelial cells, stromal spindle-shaped cells, and dermal dendrocytes in Kaposi’s sarcoma. Arch Dermatol 129(2):250–251PubMedGoogle Scholar
  171. Nicoli P, Familiari U, Bosa M, Allice T, Mete F, Morotti A, Cilloni D, Saglio G, Guerrasio A (2009) HHV8-positive, HIV-negative multicentric Castleman’s disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma. Int J Hematol 90(3):392–396PubMedGoogle Scholar
  172. Nishimoto N, Sasai M, Shima Y, Nakagawa M, Matsumoto T, Shirai T, Kishimoto T, Yoshizaki K (2000) Improvement in Castleman’s disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 95(1):56–61PubMedGoogle Scholar
  173. O’Brien TR, Kedes D, Ganem D, Macrae DR, Rosenberg PS, Molden J, Goedert JJ (1999) Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi’s sarcoma. J Infect Dis 180(4):1010–1017PubMedGoogle Scholar
  174. Ojala PM, Yamamoto K, Castanos-Velez E, Biberfeld P, Korsmeyer SJ, Makela TP (2000) The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol 2(11):819–825PubMedGoogle Scholar
  175. Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, Hamoudi R, Daniel MT, Agbalika F, Boshoff C, Clauvel JP, Isaacson PG, Meignin V (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99(7):2331–2336PubMedGoogle Scholar
  176. Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel JP, Agbalika F (2000) High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 96(6):2069–2073PubMedGoogle Scholar
  177. Oksenhendler E, Cazals-Hatem D, Schulz TF, Barateau V, Grollet L, Sheldon J, Clauvel JP, Sigaux F, Agbalika F (1998) Transient angiolymphoid hyperplasia and Kaposi’s sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N Engl J Med 338(22):1585–1590PubMedGoogle Scholar
  178. Osborne J, Moore PS, Chang Y (1999) KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol 60(10):921–927PubMedGoogle Scholar
  179. Parravicini C, Chandran B, Corbellino M, Berti E, Paulli M, Moore PS, Chang Y (2000) Differential viral protein expression in Kaposi’s sarcoma-associated herpesvirus-infected diseases: Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. Am J Pathol 156(3):743–749PubMedGoogle Scholar
  180. Parravicini C, Olsen SJ, Capra M, Poli F, Sirchia G, Gao SJ, Berti E, Nocera A, Rossi E, Bestetti G, Pizzuto M, Galli M, Moroni M, Moore PS, Corbellino M (1997) Risk of Kaposi’s sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi’s sarcoma patients. Blood 90(7):2826–2829PubMedGoogle Scholar
  181. Pati S, Cavrois M, Guo HG, Foulke JS Jr, Kim J, Feldman RA, Reitz M (2001) Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi’s sarcoma pathogenesis. J Virol 75(18):8660–8673PubMedGoogle Scholar
  182. Pelser C, Dazzi C, Graubard BI, Lauria C, Vitale F, Goedert JJ (2009) Risk of classic Kaposi sarcoma with residential exposure to volcanic and related soils in Sicily. Ann Epidemiol 19(8):597–601PubMedGoogle Scholar
  183. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grasser FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2(4):269–276PubMedGoogle Scholar
  184. Plancoulaine S, Abel L, van Beveren M, Tregouet DA, Joubert M, Tortevoye P, de The G, Gessain A (2000) Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 356(9235):1062–1065PubMedGoogle Scholar
  185. Prakash O, Tang ZY, Peng X, Coleman R, Gill J, Farr G, Samaniego F (2002) Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene. J Natl Cancer Inst 94(12):926–935PubMedGoogle Scholar
  186. Preiser W, Szep NI, Lang D, Doerr HW, Rabenau HF (2001) Kaposi’s sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems. Med Microbiol Immunol 190(3):121–127PubMedGoogle Scholar
  187. Qian LW, Xie J, Ye F, Gao SJ (2007) Kaposi’s sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases. J Virol 81(13):7001–7010PubMedGoogle Scholar
  188. Qin Z, Kearney P, Plaisance K, Parsons CH (2009) Pivotal Advance: Kaposi’s sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J Leukoc Biol 87(1):25–34Google Scholar
  189. Qunibi W, Al-Furayh O, Almeshari K, Lin SF, Sun R, Heston L, Ross D, Rigsby M, Miller G (1998) Serologic association of human herpesvirus eight with posttransplant Kaposi’s sarcoma in Saudi Arabia. Transplantation 65(4):583–585PubMedGoogle Scholar
  190. Radkov SA, Kellam P, Boshoff C (2000) The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6(10):1121–1127PubMedGoogle Scholar
  191. Regamey N, Tamm M, Wernli M, Witschi A, Thiel G, Cathomas G, Erb P (1998) Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 339(19):1358–1363PubMedGoogle Scholar
  192. Renwick N, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, Lange JM, Schulz TF, Goudsmit J (1998) Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi’s sarcoma. AIDS (London, England) 12(18):2481–2488Google Scholar
  193. Rettig MB, Ma HJ, Vescio RA, Pold M, Schiller G, Belson D, Savage A, Nishikubo C, Wu C, Fraser J, Said JW, Berenson JR (1997) Kaposi’s sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 276(5320):1851–1854PubMedGoogle Scholar
  194. Rezza G, Andreoni M, Dorrucci M, Pezzotti P, Monini P, Zerboni R, Salassa B, Colangeli V, Sarmati L, Nicastri E, Barbanera M, Pristera R, Aiuti F, Ortona L, Ensoli B (1999) Human herpesvirus 8 seropositivity and risk of Kaposi’s sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst 91(17):1468–1474PubMedGoogle Scholar
  195. Rezza G, Danaya RT, Wagner TM, Sarmati L, Owen IL, Monini P, Andreoni M, Suligoi B, Ensoli B, Pozio E (2001) Human herpesvirus-8 and other viral infections, Papua New Guinea. Emerg Infect Dis 7(5):893–895PubMedGoogle Scholar
  196. Riva G, Barozzi P, Torelli G, Luppi M (2010) Immunological and inflammatory features of Kaposi’s sarcoma and other Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias. AIDS Rev 12(1):40–51PubMedGoogle Scholar
  197. Rywlin AM, Rosen L, Cabello B (1983) Coexistence of Castleman’s disease and Kaposi’s sarcoma. Report of a case and a speculation. Am J Dermatopathol 5(3):277–281PubMedGoogle Scholar
  198. Safai B, Good RA (1981) Kaposi’s sarcoma: a review and recent developments. CA Cancer J Clin 31(1):2–12PubMedGoogle Scholar
  199. Said JW, Rettig MR, Heppner K, Vescio RA, Schiller G, Ma HJ, Belson D, Savage A, Shintaku IP, Koeffler HP, Asou H, Pinkus G, Pinkus J, Schrage M, Green E, Berenson JR (1997) Localization of Kaposi’s sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood 90(11):4278–4282PubMedGoogle Scholar
  200. Sakakibara S, Pise-Masison CA, Brady JN, Tosato G (2009) Gene regulation and functional alterations induced by Kaposi’s sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells. J Virol 83(5):2140–2153PubMedGoogle Scholar
  201. Salahuddin SZ, Nakamura S, Biberfeld P, Kaplan MH, Markham PD, Larsson L, Gallo RC (1988) Angiogenic properties of Kaposi’s sarcoma-derived cells after long-term culture in vitro. Science 242(4877):430–433PubMedGoogle Scholar
  202. Sarek G, Jarviluoma A, Moore HM, Tojkander S, Vartia S, Biberfeld P, Laiho M, Ojala PM (2011) Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency. PLoS Pathog 6(3):e1000818Google Scholar
  203. Sarek G, Jarviluoma A, Ojala PM (2006) KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas. Blood 107(2):725–732PubMedGoogle Scholar
  204. Sarek G, Kurki S, Enback J, Iotzova G, Haas J, Laakkonen P, Laiho M, Ojala PM (2007) Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas. J Clin Invest 117(4):1019–1028PubMedGoogle Scholar
  205. Sharma-Walia N, Paul AG, Bottero V, Sadagopan S, Veettil MV, Kerur N, Chandran B (2010) Kaposi’s sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion. PLoS Pathog 6(2):e1000777PubMedGoogle Scholar
  206. Shin YC, Nakamura H, Liang X, Feng P, Chang H, Kowalik TF, Jung JU (2006) Inhibition of the ATM/p53 signal transduction pathway by Kaposi’s sarcoma-associated herpesvirus interferon regulatory factor 1. J Virol 80(5):2257–2266PubMedGoogle Scholar
  207. Si H, Robertson ES (2006) Kaposi’s sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function. J Virol 80(2):697–709PubMedGoogle Scholar
  208. Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Jentsch U, Pacella-Norman R, Bourboulia D, Whitby D, Boshoff C, Weiss R (1999) Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med 340(24):1863–1871PubMedGoogle Scholar
  209. Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R (2007) Kaposi’s sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 81(23):12836–12845PubMedGoogle Scholar
  210. Slavin G, Cameron HM, Forbes C, Mitchell RM (1970) Kaposi’s sarcoma in East African children: a report of 51 cases. J Pathol 100(3):187–199PubMedGoogle Scholar
  211. Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA, Gutkind JS (2000) The Kaposi’s sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 60(17):4873–4880PubMedGoogle Scholar
  212. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d’Agay MF, Clauvel JP, Raphael M, Degos L et al (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86(4):1276–1280PubMedGoogle Scholar
  213. Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G (2005) Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med 352(13):1317–1323PubMedGoogle Scholar
  214. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, Haase AT (1997) Kaposi’s sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71(1):715–719PubMedGoogle Scholar
  215. Stein L, Urban MI, O’Connell D, Yu XQ, Beral V, Newton R, Ruff P, Donde B, Hale M, Patel M, Sitas F (2008) The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995–2004. Int J Cancer 122(10):2260–2265PubMedGoogle Scholar
  216. Suthaus J, Adam N, Grotzinger J, Scheller J, Rose-John S (2010) Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization. Eur J Cell Biol 90(6–7):495–504PubMedGoogle Scholar
  217. Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N (1997) Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390(6656):184–187PubMedGoogle Scholar
  218. Tessari G, Naldi L, Boschiero L, Cordiano C, Piaserico S, Fortina AB, Cerimele D, La Parola IL, Capuano M, Gotti E, Ruggenenti P, Sassi F, Remuzzi G, Girolomoni G (2006) Incidence and clinical predictors of Kaposi’s sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study. Eur J Dermatol 16(5):553–557PubMedGoogle Scholar
  219. Tomlinson CC, Damania B (2004) The K1 protein of Kaposi’s sarcoma-associated herpesvirus activates the Akt signaling pathway. J Virol 78(4):1918–1927PubMedGoogle Scholar
  220. Tye MJ (1970) Bullous pemphigoid and Kaposi’s sarcoma. Arch Dermatol 101(6):690–691PubMedGoogle Scholar
  221. Uldrick TS, Wang V, O’Mahony D, Aleman K, Wyvill KM, Marshall V, Steinberg SM, Pittaluga S, Maric I, Whitby D, Tosato G, Little RF, Yarchoan R (2010) An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis 51(3):350–358PubMedGoogle Scholar
  222. Ustun C, Reid-Nicholson M, Nayak-Kapoor A, Jones-Crawford J, McDonald K, Jillella AP, Ramalingam P (2009) Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome. Ann Hematol 88(4):351–358PubMedGoogle Scholar
  223. Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE (2006) Cancer incidence before and after kidney transplantation. Jama 296(23):2823–2831PubMedGoogle Scholar
  224. Vamvakas EC (2010) Is human herpesvirus-8 transmitted by transfusion? Transfus Med Rev 24(1):1–14PubMedGoogle Scholar
  225. van Kooten C, Rensink I, Aarden L, van Oers R (1993) Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells. Leukemia 7(4):618–624PubMedGoogle Scholar
  226. Verma SC, Lan K, Robertson E (2007) Structure and function of latency-associated nuclear antigen. Curr Top Microbiol Immunol 312:101–136PubMedGoogle Scholar
  227. Verschuren EW, Klefstrom J, Evan GI, Jones N (2002) The oncogenic potential of Kaposi’s sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2(3):229–241PubMedGoogle Scholar
  228. Vieira J, Huang ML, Koelle DM, Corey L (1997) Transmissible Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi’s sarcoma. J Virol 71(9):7083–7087PubMedGoogle Scholar
  229. Viejo-Borbolla A, Ottinger M, Bruning E, Burger A, Konig R, Kati E, Sheldon JA, Schulz TF (2005) Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi’s Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J Virol 79(21):13618–13629PubMedGoogle Scholar
  230. Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, Makinen T, Elliman S, Flanagan AM, Alitalo K, Boshoff C (2004a) Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36(7):687–693PubMedGoogle Scholar
  231. Wang L, Damania B (2008) Kaposi’s sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res 68(12):4640–4648PubMedGoogle Scholar
  232. Wang L, Dittmer DP, Tomlinson CC, Fakhari FD, Damania B (2006) Immortalization of primary endothelial cells by the K1 protein of Kaposi’s sarcoma-associated herpesvirus. Cancer Res 66(7):3658–3666PubMedGoogle Scholar
  233. Wang L, Wakisaka N, Tomlinson CC, DeWire SM, Krall S, Pagano JS, Damania B (2004b) The Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res 64(8):2774–2781PubMedGoogle Scholar
  234. Wang QJ, Jenkins FJ, Jacobson LP, Kingsley LA, Day RD, Zhang ZW, Meng YX, Pellett PE, Kousoulas KG, Baghian A, Rinaldo CR Jr (2001) Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins. Blood 97(8):2366–2373PubMedGoogle Scholar
  235. Wang S, Wang S, Maeng H, Young DP, Prakash O, Fayad LE, Younes A, Samaniego F (2007) K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis. Blood 109(5):2174–2182PubMedGoogle Scholar
  236. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FE, Aldam DM, Denton AS et al (1995) Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi’s sarcoma. Lancet 346(8978):799–802PubMedGoogle Scholar
  237. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G (1998) Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 90(5):395–397PubMedGoogle Scholar
  238. Whitby D, Luppi M, Sabin C, Barozzi P, Di Biase AR, Balli F, Cucci F, Weiss RA, Boshoff C, Torelli G (2000) Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission. Br J Cancer 82(3):702–704PubMedGoogle Scholar
  239. Whitby D, Marshall VA, Bagni RK, Miley WJ, McCloud TG, Hines-Boykin R, Goedert JJ, Conde BA, Nagashima K, Mikovits J, Dittmer DP, Newman DJ (2007) Reactivation of Kaposi’s sarcoma-associated herpesvirus by natural products from Kaposi’s sarcoma endemic regions. Int J Cancer 120(2):321–328PubMedGoogle Scholar
  240. Whitby D, Marshall VA, Bagni RK, Wang CD, Gamache CJ, Guzman JR, Kron M, Ebbesen P, Biggar RJ (2004) Genotypic characterization of Kaposi’s sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations. J Gen Virol 85(Pt 1):155–163PubMedGoogle Scholar
  241. Wies E, Mori Y, Hahn A, Kremmer E, Sturzl M, Fleckenstein B, Neipel F (2008) The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells. Blood 111(1):320–327PubMedGoogle Scholar
  242. Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T et al (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease. Blood 74(4):1360–1367PubMedGoogle Scholar
  243. Zanetti E, Barozzi P, Brown EE, Bosco R, Vallerini D, Riva G, Quadrelli C, Potenza L, Forghieri F, Montagnani G, D’Amico R, Del Giovane C, Duraes C, Whitby D, Machado JC, Schulz TF, Torelli G, Luppi M (2010) Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. Transplantation 90(3):337–338PubMedGoogle Scholar
  244. Zavos G, Bokos J, Papaconstantinou I, Boletis J, Gazouli M, Kakisis J, Zografidis A, Kostakis A (2004) Clinicopathological aspects of 18 Kaposi’s sarcoma among 1055 Greek renal transplant recipients. Artif Organs 28(6):595–599PubMedGoogle Scholar
  245. Zeng Y, Zhang X, Huang Z, Cheng L, Yao S, Qin D, Chen X, Tang Q, Lv Z, Zhang L, Lu C (2007) Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi’s sarcoma-associated herpesvirus: role of JAK/STAT signaling. J Virol 81(5):2401–2417PubMedGoogle Scholar
  246. Ziegler JL, Katongole-Mbidde E (1996) Kaposi’s sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer 65(2):200–203PubMedGoogle Scholar
  247. Zong JC, Ciufo DM, Alcendor DJ, Wan X, Nicholas J, Browning PJ, Rady PL, Tyring SK, Orenstein JM, Rabkin CS, Su IJ, Powell KF, Croxson M, Foreman KE, Nickoloff BJ, Alkan S, Hayward GS (1999) High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi’s sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 73(5):4156–4170PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Institute of Virology, Hannover Medical SchoolHannoverGermany

Personalised recommendations